abstract |
In its many embodiments, the present invention relates to a new class of phenylmorpholine and phenylthiomorpholine compounds which can be used as agonists for α2C-adrenergic receptor, pharmaceutical compositions containing the compounds, and methods of treating, prophylaxis, inhibiting or alleviating one or more diseases associated with the agonists of α2C adrenergic receptor using such compounds or pharmaceutical preparations. |